2,3-环氧丙酯英文名称：2,3-Epoxypropylester | 71206-09-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 2,3-环氧丙酯英文名称：2,3-Epoxypropylester
• 中文别名: 2,3-环氧丙酯
• 英文名称: glycidyl neodecanoate
• 英文别名: glycidyl ester of neodecanoic acid and epichlorohydrin；2,3-Epoxypropyl neodecanoate；oxiran-2-ylmethyl 7,7-dimethyloctanoate
• CAS: 71206-09-2
• 化学式: C₁₃H₂₄O₃
• 分子量: 228.332
• InChiKey: FIWHJQPAGLNURC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  16
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  neodecanoic acid 、 环氧氯丙烷 在 四甲基氯化铵 、 potassium hydroxide 、 sodium hydroxide 作用下， 以 水 为溶剂， 反应 12.5h， 生成 2,3-环氧丙酯英文名称：2,3-Epoxypropylester
  参考文献：
  名称：

  글리시딜 에스테르의 제조방법

  摘要：

  本发明涉及使用单羧酸酐制备甘油酯的方法，该方法不仅可以最小化未反应的羟基丙酸酯残留量以简化制造过程，而且在通常的搅拌速度和搅拌能力下，也可以制备低粘度和低含量的甘油酯，而且不会发生物理性质的变化。

  公开号：

  KR20190000640A

文献信息

• Penem derivatives and antimicrobial agents containing the same
  申请人：SUNTORY LIMITED

  公开号：EP0774465A1

  公开（公告）日：1997-05-21

  Penem derivatives represented by the following Formula (I): wherein Z represents a hydroxyl group or a fluorine atom, R1 represents a substituted or unsubstituted alkyl, alkenyl, aralkyl group, aryl group, heterocyclic, or acyl group, or a hydrogen atom, and R2 represents a hydrogen atom or a carboxyl-protecting group; and pharmacologically acceptable salts thereof are antibacterial agents effective against, inter alia, methicillin-resistant Staphylococcus aureus. The derivatives and salts are novel except when R1 is ethyl and Z is hydroxyl. The analogous compounds in which R2 is a carboxyl-protecting group and any hydroxyl group represented by Z is protected are novel process intermediates.

  Penem衍生物由以下公式（I）表示：其中Z代表一个羟基团或氟原子，R1代表一个取代或未取代的烷基，烯基，芳基甲基，芳基，杂环基或酰基，或氢原子，R2代表一个氢原子或羧基保护基；及其药理学上可接受的盐是有效的抗菌剂，可用于治疗耐甲氧西林金黄色葡萄球菌等感染。这些衍生物和盐是新颖的，除非R1是乙基且Z是羟基。其中R2是羧基保护基且Z代表的任何羟基被保护的类似化合物是新颖的工艺中间体。
• [EN] HYDROXYAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF HISTONE DEACETYLASE (HDAC)<br/>[FR] COMPOSÉS D'HYDROXYAMIDE PRÉSENTANT UNE ACTIVITÉ EN TANT QU'INHIBITEURS D'HISTONE DÉSACÉTYLASE (HDAC)
  申请人：ASTELLAS PHARMA INC

  公开号：WO2006016680A1

  公开（公告）日：2006-02-16

  A compound having the following formula (I): wherein R1 is hydrogen, lower alkyl, lower alkenyl, lower or higher alkynyl, cyclo(lower)alkyl, cyclo(higher)alkyl, cyclo(lower)alkyl(lower)alkyl, cyclo(higher)alkyl(lower)alkyl, cyclo(lower)alkenyl(lower)alkyl, aryl-fused cyclo(lower)alkyl, lower alkoxy, acyl, aryl, ar(lower)alkoxy, ar(lower)alkyl, heteroar(lower)alkyl, amino, heteroaryl, heterocyclyl or heterocyclyl(lower)alkyl, which may be substituted with one or more suitable substituent(s),R2 is hydrogen or lower alkyl, X is arylene, heteroarylene, cycloalkylene, heterocycloalkylene or aryl-fused cycloalkylene, Y is arylene or heteroarylene, which may be substituted with one or more suitable substituent(s), Z is lower alkenylene, which may be substituted with lower alkyl or halogen, or a salt thereof. The compound is useful as a histone deacetylase inhibitor.

  一种具有以下化学式（I）的化合物：其中R1是氢、低烷基、低烯基、低或高炔基、环（低）烷基、环（高）烷基、环（低）烷基（低）烷基、环（高）烷基（低）烷基、环（低）烯基（低）烷基、芳基-融合环（低）烷基、低烷氧基、酰基、芳基、芳基（低）氧基、芳基（低）烷基、杂环芳基（低）烷基、氨基、杂环芳基、杂环烷基或杂环烷基（低）烷基，可以用一个或多个适当的取代基替换；R2是氢或低烷基，X是芳基、杂环芳基、环烷基、杂环环烷基或芳基-融合环烷基，Y是芳基或杂环芳基，可以用一个或多个适当的取代基替换；Z是低烯基，可以用低烷基或卤素取代，或其盐。该化合物可用作组蛋白去乙酰化酶抑制剂。
• MULTI-AZIRIDINE COMPOUND
  申请人：DSM IP ASSETS B.V.

  公开号：US20210332031A1

  公开（公告）日：2021-10-28

  The present invention relates to a multi-aziridine compound having: a) from 2 to 6 of the following structural units (A): (A) whereby R′, R″, R 1 , R 2 , R 3 and R 4 are as defined herein m is an integer from 1 to 6; b) one or more linking chains wherein each one of these linking chains links two of the structural units A; and c) a molecular weight in the range from 600 Daltons to 5000 Daltons. The multi-aziridine compound can be used for example for crosslinking of for example carboxylic acid functional polymers dissolved and/or dispersed in an aqueous medium.

  本发明涉及一种多环氮丙烷化合物，其具有：a) 2至6个以下结构单元（A）：（A），其中R′、R″、R1、R2、R3和R4如本文所定义，m为1至6的整数；b) 一个或多个连接链，其中每个连接链连接两个结构单元A；以及c) 分子量在600道尔顿至5000道尔顿范围内。该多环氮丙烷化合物可用于例如交联溶解和/或分散在水性介质中的羧酸官能聚合物。
• Propanolamine derivatives
  申请人：Fujisawa Pharmaceutical Co. Ltd.

  公开号：US20020120148A1

  公开（公告）日：2002-08-29

  This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]: 1 Wherein each symbol is as defined in the specification or salts thereof which have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment diseases indicated in the specification to a human being or an animal.

  这项发明涉及新的丙醇胺衍生物或其盐，其化学式如下所示：1其中每个符号如规范中定义，或具有选择性肠道交感神经兴奋作用、抗溃疡、抗胰腺炎、脂解作用、抗尿失禁和抗尿频活性的盐，以及其制备方法、包含相同的药物组合物以及用于预防和/或治疗规范中指示的疾病的方法，适用于人类或动物。
• Methods for Making Functionalized Fluorinated Monomers, Fluorinated Monomers, and Compositions for Making the Same
  申请人：Etna-TEC, Ltd.

  公开号：US20180334417A1

  公开（公告）日：2018-11-22

  A method of making a functionalized fluorinated monomer for use in making oligomers and polymers that can be used to improve surface properties of polymer-derived systems, such as coatings. The method of making a functionalized fluorinated monomer includes reacting at least one fluorinated nucleophilic reactant, such as a fluorinated alcohol, with at least one compound containing at least one epoxide group. Other methods include reaction of a fluorinated alcohol with a cyclic carboxylic anhydride. In another embodiment, a method includes reacting a fluorinated mesylate, tosylate or triflate with an amine, alkoxide or phenoxide. In other embodiments, the method includes reacting a fluorinated alcohol with an alkyl halide, or reacting a fluorinated alkyl halide with an amine. The functionalized fluorinated monomers may be used as intermediates and reacted to modify the functional groups thereon. Further, the functionalized fluorinated monomers may be reacted to form polymers or oligomers, or with polymers or oligomers having functional groups to modify the polymer or oligomer through the functional group thereon,

  一种制备用于制备寡聚物和聚合物的官能化氟化单体的方法，可用于改善聚合物衍生系统（如涂层）的表面性能。制备官能化氟化单体的方法包括将至少一种氟化亲核试剂（如氟化醇）与至少一种含有至少一个环氧基团的化合物反应。其他方法包括将氟化醇与环状羧酸酐反应。在另一实施例中，一种方法包括将氟化甲磺酸酯、对甲苯磺酸酯或三氟甲烷磺酸酯与胺、烷氧基或苯氧基反应。在其他实施例中，该方法包括将氟化醇与烷基卤化物反应，或将氟化烷基卤化物与胺反应。这些官能化氟化单体可用作中间体，并可反应以修改其上的官能基团。此外，这些官能化氟化单体可用于与聚合物或寡聚物反应，或与具有官能基团的聚合物或寡聚物反应，通过其上的官能基团修改聚合物或寡聚物。